international gynecologic cancer symposium...

Uniting the Globe in the Fight Against Gynecologic Cancer

FINAL PROGRAMME

REGIONAL IGCS MEETING 2015SANTIAGO, CHILE MAY 10-12, 2015

TH

International Gynecologic Cancer Society

www.igcsregional.com www.igcs.org

The Chilean Society of Obstetrics and

Gynecology (SOCHOG)

The Chilean Society of Gynecologic Oncology

(SCHIGO)

www.igcs2016.com

16TH BIENNIAL MEETING OF THE

INTERNATIONAL GYNECOLOGIC CANCER

SOCIETYOctober 29 - 31, 2016

Lisbon, Portugal

UNITING THE GLOBE IN THE FIGHT AGAINST GYNECOLOGIC CANCER

Meeting Secretariat:Kenes International7, rue François-Versonnex C.P. 60531211 Geneva 6, SwitzerlandTel: +41 (22) 908-0488, Fax: +41 (22) 906-9140E-mail: [email protected]: www.igcs2016.com

For Membership: International Gynecologic Cancer Society (IGCS), PO Box 6387Louisville, KY 40206, USATel: +1 (502) 891-4575 Fax: +1 (502) 891-4576E-mail: [email protected]: www.igcs.org

SYMPOSIUM ROCHEProgram Symposium

4th Regional IGCS Meeting 2015, SantiagoMay 10, 2015

Hotel Intercontinental

12:30 -12:35 hrs. Welcome Dra. Ximena Ahumada

12:35 -12:50 hrs. Introduction Cervical Cancer in Chile Dr. Nicanor Barrena

12:50 -13:20 hrs. "Update in the management of Dr. Krishnansu S. Tewari advanced cervical cancer, the role of bevacizumab, 13:20 - 13:30 hrs. Discussion

4

TABLE OF CONTENTS

MEETING INFORMATION Venue Map 5

Welcome Letter 6

Committees 7

General Information 8

About Santiago 10

Information for Presenters and Chairpersons 11

Poster Session Overview 12

SCIENTIFIC PROGRAMME Sunday, May 10, 2015 13

Monday, May 11, 2015 17

Tuesday, May 12, 2015 20

Poster Session 21

Index of Authors 29

RECOGNITION, ACKNOWLEDGEMENTS AND INDUSTRY SUPPORTAcknowledgements 32

Company Organised Satellite Symposium 32

Exhibitor and Sponsor Profiles 33

IGCS2015

5

VENUE MAP RE

GIST

RAT

ION

HALL B HALL A

REGI

STRA

TIO

N

EXHIBITION AREA HALL A

POSTER AREA

TUESDAY, MAY 12

SUNDAY, MAY 10 AND MONDAY, MAY 11

6

Dear Colleagues,

On behalf of IGCS President Richard Barakat, the Scientific Programme Committee, the Local Organizing Committee, the Chilean Society of Gynecologic Oncology (SCHIGO), the Chilean Society of Obstetrics and Gynecology (SOCHOG) and the Officers and Council of the IGCS, it is our great pleasure to welcome you to the 4th IGCS Regional Meeting on Gynecologic Cancers taking place in Santiago, one of the most attractive and beautiful cities in South America.

Santiago is Chile's capital city. The imposing Andes Mountains rise majestically around it, with their snow-capped summits and hills that slope down to the very heart of the city. Its setting in the center of a fertile valley and its pleasant Mediterranean climate make it a modern and lively city all year round. From a tourist point of view and due to its location, you are able to be on the mountains, watching the ocean or enjoying different landscapes all in less than a ninety-minute drive.

IGCS Regional Meetings offer collaborative state-of-the-art educational sessions on topics, including cancer prevention, surgical techniques, chemotherapy, radiation therapy, and palliative care. Over three full days, attendees will have the opportunity to participate in lectures, tumor boards, debates, and live surgical training.

We look forward to welcoming you to the congress and wish you a pleasant stay.

WELCOME LETTER

Dr. Raimundo Correa Co-Chair, Scientific Programme Committee

Dr. Michael A. Bookman Co-Chair, Scientific Programme Committee

Dr. Richard Barakat President, IGCS

IGCS2015

7

COMMITTEES

INTERNATIONAL GYNECOLOGIC CANCER SOCIETY OFFICERSPresident Richard R. Barakat, USA Past President Lynette A. Denny, South Africa President Elect Michael A.Quinn, AustraliaVice President Allan L. Covens, CanadaSecretary-Treasurer Robert L. Coleman, USA Secretary-Treasurer Elect Walter H. Gotlieb, Canada

INTERNATIONAL GYNECOLOGIC CANCER SOCIETY COUNCIL MEMBERSNadeem R. Abu-Rustum, USARoberto Angioli, ItalyHennie Botha, South AfricaPatricia J. Eifel, USAGini F. Fleming, USAThomas J. Herzog, USAJoo-Hyun Nam, KoreaAikou Okamoto, JapanElvio G. Silva, USA

SCIENTIFIC PROGRAMME COMMITTEE Michael A. Bookman, USA – Co-Chair Raimundo Correa, Chile – Co-ChairHennie Botha, South Africa Allan Covens, CanadaMauricio Cuello, ChileWalter Gotlieb, CanadaDavid Mayerson, Chile Raúl Puente, Chile

LOCAL ORGANIZING COMMITTEERaimundo Correa, Local ChairClemente ArabMauricio Cuello (President, SOCHOG)Jorge Brañes Juan Enrique LeivaDavid Mayerson (Past President, SCHIGO)Raúl Puente (President, SCHIGO)

8

GENERAL INFORMATION

MEETING VENUEThe Intercontinental SantiagoVitacura 2885, Las Condes, Región Metropolitana, ChilePhone:+56 2 2394 2000http://www.intercontinental.com/hotels/gb/en/santiago/sclha/hoteldetail

REGISTRATIONThe Registration Desk will be open at the Intercontinental Santiago Hotel as follows:Saturday, May 9, 2015 16:30-20:00 Sunday, May 10, 2015 08.00 -19:00Monday, May 11, 2015 08:00-17:30Tuesday, May 12, 2015 08:00-14:00

PARTICIPANT BADGESUpon registration, you will receive your name badge. You are kindly requested to wear your badge during all Meeting sessions and events.

WIFIFree WIFI will be available at the Meeting. Please be aware that public WIFI capacityis always limited and thefore activities are limited to email and web browsing.Network Name: Intercontinental | Password: igcsreg15

REFRESHMENTSCoffee and lunch will be served in the Exhibition and Poster area at the times indicated in the Scientific Programme.

EXHIBITION OPENING TIMES Sunday May 10, 2015 09:45-19:00Monday, May 11, 2015 09:45-16:30

MEETING ABSTRACTS AVAILABLE ONLINE All the Meeting abstracts are published as an online supplement to the International Journal of Gynecologic Cancer: Volume 25, Supplement 1.

PHOTOGRAPHY AND RECORDING PRIVILEGESNo photography, video recording or audio recording is permitted in the scientific sessions at this Meeting unless otherwise authorized by the Scientific Committee or the Meeting Chairman.

IGCS2015

9

SAFETY AND SECURITYPlease do not leave any bags or suitcases unattended at any time, whether inside or outside session halls.

SMOKING POLICYParticipants are kindly requested to refrain from smoking in all session rooms, poster areas and exhibition.

GUEST ATTENDANCE POLICYAll event activities (including educational sessions, meal functions, exhibit hall, etc.) are exclusively reserved for registered attendees. Non-registered guests (including children, family members, colleagues, etc.) are not allowed in any of the event areas. Badges provided at registration are required for entrance into all functions. This policy will be strictly enforced.

CARING FOR THE ENVIROMENTThe Meeting and appointed Meeting organiser Kenes International are devoted to considering environmentally friendly practice at this meeting and in all of our operations. Our responsibility to our Meeting participants, staff, environment and society is paramount in all of our decisions, policies and practices. We continue to learn and strive to integrate new practices all the time.

IGCS MEMBERSHIPTo learn more about IGCS or to apply for membership, please visit the IGCS desk. For further information refer to www.igcs.org or contact the IGCS administration office at [email protected]

INTERNATIONAL GYNECOLOGIC CANCER SOCIETY (IGCS)PO Box 6387Louisville, KY 40206, USATel: +1 (502) 891 4575Fax: + 1 (502) 891 4576 E-mail: [email protected] Website: www.igcs.org

MEETING SECRETARIAT

7 rue François-Versonnex, C.P. 60531211 Geneva 6, SwitzerlandTel: +41 22 908 0488Fax:+41 22 906 9140E-mail: [email protected]: www.igcsregional.com

10

ABOUT SANTIAGO

Founded in 1541, Santiago has been the capital city of Chile since colonial times. The city has a downtown core of 19th century neoclassical architecture and winding side-streets, dotted by art deco, neo-gothic, and other styles. Mountains of the Andes chain can be seen from most points in the city. The city outskirts are surrounded by vineyards, and Santiago is within a few hours of both the mountains and the Pacific Ocean.

Santiago's steady economic growth over the past few decades has transformed it into a modern metropolis.

Only a few historical buildings from the Spanish colonial period remain in the city. In the center of Santiago are several buildings built during the Spanish domination and that mostly correspond to, as the Metropolitan Cathedral begun in 1748 and ended in 1800 and the Church of San Francisco (1586). Other buildings of the period are those located on the sides of Plaza de Armas, established as the city square in 1541. These include the former seat of government, the Palacio de la Real Audiencia de Santiago built between 1804 and 1807, and the Casa Colorada (1769).

Most of the museums are located in the historic city center, occupying the old buildings of colonial origin, such as the National History Museum, located in the Palacio de la Real Audiencia. La Casa Colorada houses the Museum of Santiago, while the Colonial Museum is housed in a wing of the Church of San Francisco. The Museum of Fine Arts, though it is located in the city center, was built in the early twentieth century, and the Museum of Contemporary Art established in 1947.

The Quinta Normal Park, was founded in 1841 for greenhouses to cultivate foreign plant species. The park is now 35.5 hectares (88 acres). The park has a new water feature that include paddle boats. There are also several museums, Artequin Museum an interactive and educational art museum, the Museum of Science and Technology and the train museum, Museo Ferroviario.

There is an extensive network of bicycle trails in the city, especially in the Providencia comuna. The longest section is the Americo Vespuccio road, which contains a very wide dirt path with many trees through the center of a street used by motorists on both sides. The next longest path is along the Mapocho River along avenida Andrés Bello.

IGCS2015

11

Please check the PROGRAMME in case of last minute scheduling changes.

ORAL PRESENTATIONS DATA PRESENTATION:If using a PowerPoint (or any other computer) presentation, please note you need to bring it on a CD, a DVD or on a “disk on key” Memory stick (using the USB port in the computer) and load it on one of the Meeting’ computers in the hall you are speaking in, at least 1 hour before the start of the session.

Please note that the Meeting computers in the session halls are being supplied with Office 2010.

Alternatively you may supply your own laptop computer. In such a case please confirm that it has a VGA socket for external signal and come to check it first in the hall you are speaking in as soon as you arrive.

IMPORTANT NOTE FOR MACINTOSH USERSIn order to use MAC presentations on a PC compatible computer please note that you need to prepare it according to the instructions below, before bringing it to the hall:

1. Use a common font, such as Arial, Times New Roman, Verdana etc. (special fonts might be changed to a default font on a PowerPoint based PC).

2. Insert pictures as JPG files (and not TIF, PNG or PICT-these images will not be visible on a PowerPoint based PC ).

3. Use a common movie format, such as AVI and WMV (MOV files from QuickTime will not be visible on a PowerPoint based PC).

Alternatively you may use your own Macintosh laptop computer. In such a case please confirm you provide it with a VGA adaptor for external signal and come to check it first in the hall you are speaking in as soon as you arrive.

Please note that VHS Video projection, 35 mm’ slide projection and Overhead projection (projection of transparencies) will not be available.

INFORMATION FOR PRESENTERS AND CHAIRPERSONS

12

POSTER PRESENTATIONS

Please see the scientific programme for the board number on which you should display your poster. There is one poster session scheduled for Sunday, May 10, 2015 - Monday, May 11, 2015

POSTER MOUNTING AND DISMANTLINGPoster Presentations will be on display for the duration of the Meeting.

Posters may be mounted between 07:00 – 08:00 on Sunday, May 10, 2015 and dismantled at end of day on Monday, May 11, 2015.

Each poster presenter is requested to stand by his/her poster for informal discussion during the morning and afternoon coffee/lunch breaks.

POSTER AREAAll poster boards will be situated in the poster area.

POSTER SESSION OVERVIEW Topic Board Number

Breast Cancer 1-5

Cervical Cancer 6-31

Gestational Trophoblastic Neoplasia 32-33

Imaging / Staging 34-35

Nursing, Symptom Management, Palliation 36-38

Ovarian Cancer 39-52

Uterine Cancer, including Sarcoma 53-58

Vulvar and Vaginal Cancer 59-60

Presentation No.

SCIENTIFIC PROGRAMME

13

SCIENTIFIC PROGRAMMESUNDAY, MAY 10, 2015

8:45 - 10:15 Hall A

INTERNATIONAL OPPORTUNITIESChairs: M. Quinn (Australia) 1 A. Bermudez (Argentina) 2

8:45 Welcome to Santiago and the IGCS Regional Meeting 3R. Correa (Chile)

9:00 PRESIDENTIAL ADDRESS: What Latin American Oncologists Should Expect from IGCS 4R. Barakat (USA)

9:15 How Latin America Could Contribute to Gynecologic Oncology Research 5M. Bookman (USA)

9:30 Current Status of Collaborative Clinical Research in South America 6A. Lopes da Silva Filho (Brazil)

9:45 The Role of Palliative Care / Supportive Oncology Team 7R. Correa (Chile)

10:00 Panel Discussion, Regional Clinical Research 8

10:15 - 10:30

COFFEE BREAK

SUN

DAY, M

AY 10, 2015

Presentation No.

SUNDAY, MAY 10, 2015

14

10:30 - 11:30 Hall A

EMERGING SURGICAL PRACTICEChairs: T. Herzog (USA) 14 D. Mayerson (Chile) 15

10:30 Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Staging Approach 16N. Abu-Rustum (USA)

10:45 Role of Laparoscopy in Gynecologic Oncology 17A. Covens (Canada)

11:00 Advantages of Robotic Surgery over Laparoscopic Approach in Gynecological Malignancies 18W. Gotlieb (Canada)

11:15 Panel Discussion, Regional Surgical Practices 19

11:30 - 12:30 Hall A

MANAGEMENT OF VULVAR CANCERChairs: M. Plante (Canada) 9 A. Zevallos (Peru) 10

11:30 Surgical Considerations in the Management of Vulvar Cancer 11H. Botha (South Africa)

11:50 Adjuvant Treatment for Vulvar Cancer 12P.J. Eifel (USA)

12:10 Panel Discussion, Vulvar Cancer Management (+/- case presentation) 13

12:30 - 13:30 Exhibition Area

LUNCH BREAK

SUN

DAY

, MAY

10,

201

5

Presentation No.


15

12:30 - 13:30 Hall A

SYMPOSIUM SPONSORED BY ROCHE CHILE LTDA: UPDATE IN THE MANAGEMENT OF ADVANCED CERVICAL CANCER, THE ROLE OF BEVACIzUMAB 12:30 Welcome

X. Ahumada (Chile)

12:35 Introducción Cáncer Cérvix en Chile N. Barrena (Chile)

12:50 Update in the management of advanced cervical cancer, the role of Bevacizumab K. S. Tewari (USA)

13:20 Discussion

13:30 - 15:30 Hall A

CERVICAL CANCER IChairs: R. Anorlu (Nigeria) 21 H. Ramirez (Colombia) 22

13:30 Strategies for Cervical Cancer Prevention in Latin America: Past, Present and Future 23S. Tatti (Argentina)

14:00 Panel Discussion: Cervical Cancer Prevention 24A. Velasquez (El Salvador), O. Nazzal (Chile), J. Tisné (Chile)

14:30 Fertility Sparing Options in Cervical Cancer 27M. Plante (Canada)

14:50 Radical Abdominal Trachelectomy with SLN for Stage IB1 Cervical Cancer 28N. Abu-Rustum (USA)

15:10 Panel Discussion, Fertility Sparing Surgery 29

SUN

DAY, M

AY 10, 2015

Presentation No.

SUNDAY, MAY 10, 2015

16


COFFEE BREAK

16:00 - 17:30 Hall A

CERVICAL CANCER IIChairs: G. Fleming (USA) 31 G. Herbert (Mexico) 32

16:00 Is There a Role for Neoadjuvant Chemotherapy of Cervical Cancer? 33A. Soderini (Argentina)

16:20 Optimal Integration of Radiation Therapy in the Management of Locally Advanced Cervical Cancer 34P.J. Eifel (USA)

16:40 Uterine Sarcomas 35T. Herzog (USA)

17:00 - 17:30 Hall A

TUMOR BOARD I17:00 TUMOR BOARD: Cervical Cancer (Regional Cases)

Speakers and Chairs: G. Baiocchi (Brazil) 36 J. Rutgers (USA) 37

K.S. Tewari (USA) 37A

17:45

OPENING CEREMONY

SUN

DAY

, MAY

10,

201

5

Presentation No.


17

Presentation No.

SCIENTIFIC PROGRAMMEMONDAY, MAY 11, 2015

8:30 - 10:30 Hall A

ENDOMETRIAL CANCERChairs: A. Okamoto (Japan) 38 R. Puente (Chile) 39

8:30 Current Staging and Pathological Considerations in Endometrial Cancer 40J. Rutgers (USA)

8:50 Clinical Significance of Non-Endometrioid Tumors 41M. Bookman (USA)

9:10 Radiotherapy in Endometrial Cancer 42P.J. Eifel (USA)

9:30 Chemotherapy in Endometrial Cancer 43G. Fleming (USA)

9:50 Panel Discussion, Endometrial Cancer (+/- cases) 44


COFFEE BREAK AND POSTER VIEWING

MO

ND

AY, MAY 11, 2015

Presentation No.

MONDAY, MAY 11, 2015

18

Presentation No.

11:30 - 12:45 Hall A

ABSTRACT PRESENTATIONSChairs: M. Bookman (USA) R. Puente (Chile)

11:30 NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL SURGERY COMPARED WITH CONCURRENT CHEMOTHERAPY IN STAGE IB2- IIIB CERVICAL CANCER. LONG-TERM RESULTS IN A PROSPECTIVE RANDOMIzED TRIAL 46J. Vidaurreta, E. Castro Nessim, S. Bover, C. Hernandez, N. Vargas, C. Vico (Argentina)

11:40 Discussion 47

11:45 SURVIVAL COMPARISONS BETWEEN PRIMARY DEBULKING SURGERY AND NEO-ADJUVANT CHEMOTHERAPY IN THE MANAGEMENT OF ADVANCED EPITHELIAL OVARIAN CANCER - AN ANALYSIS OF SEER-MEDICARE DATA 48G. Forde, J. Chang, A. ziogas, R. Bristow (USA)

11:55 Discussion 49

12:00 ASSIGNING SITE OF ORIGIN IN HIGH GRADE SEROUS CANCER - BRIDGING THE GAP BETWEEN RESEARCH AND CLINICAL PRACTICE 50S. Lio, J. Arseneau, O. Basso, L. Gilbert (Canada)

12:10 Discussion 51

12:15 ROLE OF VIDEO-ASSISTED THORACOSCOPY IN ADVANCED OVARIAN CANCER 52J. Di Guilmi, G. Salvo, A.M. Nick, A.K. Sood, R.L. Coleman, K.H. Lu, R. Mehran, A. Vaporciyan, P.T. Ramirez (Argentina)

12:25 Discussion 53

12:30 NEOADJUVANT CHEMOTHERAPY IN VULVAR CANCER: A POSSIBLE NEW TREND IN LOCALLY ADVANCED DISEASE 54A. Aragona, A. Soderini, N. Cuneo, C. Reyes, S. Leckmann, A. Greco (Argentina)

12:40 Discussion 55

MO

ND

AY, M

AY 1

1, 2

015

Presentation No.


19

Presentation No.


LUNCH BREAK

14:00 - 16:20 Hall A

OVARIAN CANCERChairs: M. Bookman (USA) 57 L.M. Campbell (Brazil) 58

14:00 Pathological Features of Epithelial Ovarian and Associated Cancers 59J. Rutgers (USA)

14:20 Low Malignant Potential Ovarian Tumors 60M. Bookman (USA)

14:40 Is There a Role for Adjuvant Treatment of Early Stage Disease (Serous and Non-serous)? 61M. Quinn (Australia)

15:00 The Role of Neoadjuvant Therapy and Definitions of Residual Disease in 2015 62A. Covens (Canada)

15:20 Optimal Primary Chemotherapy, including Dose-Dense and Intraperitoneal Therapy 63K. Fujiwara (Japan)

15:50 Targeting Recurrent Ovarian Cancer 64J. Ledermann (United Kingdom)

16:20 - 17:30 Hall A

TUMOR BOARD II TUMOR BOARD: Ovarian Cancer (Regional Cases)

Speakers and Chairs: C. Salas (Chile) 65 J. Rutgers (USA) 66 N. Barrena (Chile) 66A

MO

ND

AY, MAY 11, 2015

Presentation No.

TUESDAY, MAY 12, 2015

20

Presentation No.

SCIENTIFIC PROGRAMMETUESDAY, MAY 12, 2015

8:30 - 14:00 Hall A

LIVE SURGICAL SESSIONSChairs: M. Cuello (Chile) 66B J. E. Leiva (Chile) 66C

Surgical Suite Chairs: J. Brañes (Chile) 66D N. Barrena (Chile) 66E

International Surgical Faculty: N. Abu-Rustum (USA) 66F H. Botha (South Africa) 66G

9:00 - 11:00 Hall B

RADIATION ONCOLOGY WORKSHOP: RADIATION ONCOLOGY SYMPOSIUM - CONTOURING AND TARGET VOLUME DEFINITION

Speakers: P.J. Eifel (USA) 66H

A. Cordova (Chile) 66I

14:00 Hall B

FINAL REMARKS AND CLOSE

TUES

DAY

, MAY

12,

201

5

Poster No.

Presentation No.

POSTERS

21

POSTERS

01. Breast Cancer1 NEOADYUVANT HORMONOTHERAPY IN LOCALLY ADVANCED BREAST

CANCER, POSMENOPAUSIC WOMEN WITH HORMONAL RECEPTORS POSITIVE. 75N. Arturo, A. Novoa (Mexico)

2 SERIAL RESECTIONS IN METASTATIC BREAST CANCER 76N. Bacabasa, I. Dinu, A. Martiniuc, L. David (Romania)

3 COSMETIC OUTCOME ASSESSMENT AFTER NEOADJUVANT RADIOCHEMOTHERAPY IN BREAST CANCER PATIENTS 77E. Boelke, W. Budach, V. Speer, S. Wollandt, P.A. Gerber, W. Audretsch, C. Nestle Krämling, C. Matuschek (Germany)

4 MANAGEMENT OF MICROMETASTASIS FOUND ON SENTINEL LYMPH NODE BIOPSY USING OSNA IN PATIENTS DIAGNOSED WITH EARLY BREAST CANCER 78M. Chopra, F. Alam, Y. Mir, S. Mc Pherson, L. Richards, H. Wong (United Kingdom)

5 NEW ASPECTS REGARDING NEOADJUVANT RADIOCHEMOTHERAPY IN LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER AND PREDICTIVE FACTORS FOR A PATHOLOGIC COMPLETE REMISSION 79C. Matuschek, E. Boelke, W. Budach, V. Speer, H. Bojar, W. Audretsch, K. Nestle (Germany)

02. Cervical Cancer6 ACCURACY OF 18 F-FDG PET/CT FOR THE DETECTION OF PARA-AORTIC

LYMPH NODE METASTASIS IN PATIENTS WITH EARLY BULKY AND LOCALLY ADVANCED UTERINE CERVICAL CARCINOMA.FIRST NATIONAL EXPERIENCE 80D. Acuña Aravena, R. Pruzzo, N. Barrena, H. Amaral, P. Torres, Y. McConell, S. Ramírez (Chile)

7 ATYPICAL HEPATECTOMY FOR LIVER METASTASES FROM CERVICAL CANCER 81N. Bacabasa, I. Balescu, C. Stoica (Romania)

POSTERS

Poster No.

Presentation No.

POSTERS

22

8 CLINICAL ADVANTAGES OF NERVE-SPARING RADICAL HYSTERECTOMY OF CERVICAL CANCER 82S. Parry, H. Riesle, C. Bazan (Chile)

9 CERVICAL CANCER AND PREGNANCY: THREE CASES DURING 2014 IN CARLOS VAN BUREN HOSPITAL, VALPARAISO-CHILE 83H. Riesle, S. Parry, C. Bazan (Chile)

10 AVALIATION OF RESIDUAL DISEASE IN HYSTERECTOMY SPECIMENS AFTER CONIzATION IN WOMEN TREATED FOR SQUAMOUS MICROINVASIVE CARCINOMA OF THE UTERINE CERVIX 84C.A. Hartman, M.S.C. Gurgel, J.C. Teixeira, S.M. Figueiredo, J.Y. Yoneda, O.F. Rangel, J. Braganca Bastos (Brazil)

11 O&G RESIDENTS IN BRAzIL WOULD CONSIDER GYNECOLOGIC ONCOLOGY AS A SUBSPECIALTY IF IT WERE OFFICIALLY RECOGNIzED AND DON'T FEEL READY TO PERFORM RADICAL HYSTERECTOMIES 85L. Campbell, W. Primo, R. Miziara, P. Brito, L. Casulari (Brazil)

12 SURVIVAL OF CERVICAL CANCER TYPE SQUAMOUS AND ADENOCARCINOMA IN PATIENTS FROM THE NATIONAL CANCER INSTITUTE, BETWEEN 2009-2013, CHILE 86P. Gayan, M. Villalobos, C. Wendling, C. Sierra, O. Valencia, M. Carcamo, S. Prado, A. Selman, J. Garrido (Chile)

13 CLINICAL OUTCOMES AND HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WHO HAD UNDERGONE TOTAL LAPAROSCOPIC VERSUS TOTAL ROBOTIC RADICAL HYSTERECTOMY FOR CERVICAL CARCINOMA 87H. Dae Gy, J.Y. Kim, Y.H. Lee, G.O. Chong, Y.S. Lee, Y.L. Cho (Korea)

14 THE VALUE OF CYTOKERATIN 19 AND HUMAN PAPILLOMA VIRUS DNA AS MICROMETASTASIS MARKERS IN CERVICAL CANCER PATIENTS WITH INTERMEDIATE RISK FACTORS 88H. Dae Gy, M.J. Kim, Y.H. Lee, G.O. Chong, Y.S. Lee, Y.L. Cho, J.Y. Park (Korea)

15 LAPAROSCOPIC RADICAL TRACHELECTOMY: TECHNIQUE, FEASIBILITY AND OUTCOMES. EXPERIENCE HOSPITAL ITALIANO BUENOS AIRES, ARGENTINA 89J.M. Saadi, M. Perrotta, M. Giavedoni, G. Salvo, R. Orti (Argentina)

16 APOPTOTIC PATHWAY OF zINC ON CERVICAL CANCER CELL LINE 90S.N. Bae, E.Y. Ki, H.K. Chang, Y.K. Lee, K.H. Lee (Korea)

POST

ERS

Poster No.

Presentation No.

POSTERS

23

17 VAGINAL RADICAL TRACHELECTOMY. A 10 YEARS EXPERIENCE OF 3 CENTERS IN CHILE 91A. Lehuede Massa, N. Saez Orellana, M. Cuello Fredes, K. Garcia Astudillo, D. Majerson Burztyn, C. Paredes Martinez, M. Hinostroza Scheel, D. Young Hwang, J. Brañes Yunusic (Chile)

18 TREATMENT AND OUTCOME OF STAGE I A1 SQUAMOUS CARCINOMA OF THE CERVIX: A CLINICOPATHOLOGIC STUDY OF 346 CASES 92M.R. Liang, S.Y. zeng, W. Jiang, L. Li, M.L. zhong, O.P. Huang (China)

19 LAPAROSCOPIC PARAAORTIC INFRARENAL LYMPHADENECTOMY: ANATOMICAL ANOMALIES FOUND IN OUR SERIES OF CASES AT THE GYNECOLOGIC ONCOLOGY SECTION , DEPARTMENT OF GYNECOLOGY , HOSPITAL ITALIANO DE BUENOS AIRES. 93F. Noll, J. Saadi, D. Odetto, G. Saraniti, M. Perrotta (Argentina)

20 LAPAROSCOPIC POSTERIOR EXENTERATION IN CERVICAL CANCER: INITIAL EXPERIENCE AT HOSPITAL ITALIANO DE BUENOS AIRES 94D. Odetto, J. Saadi, G. Saraniti, F. Noll, G. Salvo, M. Perrotta (Argentina)

21 HYPOXIA AND BIOMARKERS EXPRESSION IN CERVICAL CANCER (CC) AND HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL) 95M.A. Ostojich, S. Gianni, L. Marino, E. Lupo, D. De Dios, N. zeff, L. Lay, F. Damiani, A. Sanchez, L. Gimenez, M.A. Jasnis (Argentina)

22 SURVIVAL IN CERVICAL CANCER PATIENTS TREATED BY MINIMALLY INVASIVE SURGERY 96S. Pessini, G.P.G. Silveira, M.P. Salcedo, M.C.B. Anselmi (Brazil)

23 POSITIVE MARGINS IN COLD KNIFE CONE: PREVALENCE AND RESIDUAL LESIONS 97R.V. Almeida, M.P. Salcedo, D. Gottlieb, D.P. Todeschini, S.A. Pessini (Brazil)

24 BIOMARKER ASSESSMENT IN CERVICAL UTERINE CANCER 98R. Medina-Berlanga, S. Blancas, L. Santos (Mexico)

25 TREATMENT OUTCOMES OF PATIENTS WITH EARLY STAGE CERVICAL CANCER TREATED WITH LAPAROTOMY COMPARED TO ROBOTICALLY ASSISTED LAPAROSCOPIC APPROACH 99K. Seader, S. Rao, Y. Hemida, E. Hashemi, M. Pitter, P. Anderson, G. Sommers (USA)

POSTERS

Poster No.

Presentation No.

POSTERS

24

26 DETECTION OF E6-E7 MRNA OF HIGH RISK HUMAN PAPILLOMAVIRUS IN NEGATIVE LYMPH NODES IN PATIENTS WITH CERVICAL CANCER: A POSSIBLE EARLY BIOMARKER OF SUBCLINICAL METASTASIS 100J.A. Basiletti, M.A. Picconi, S. Vornetti, A. Soderini, N. Cúneo, G. Etcheverry, L.V. Alonio (Argentina)

27 THE ABDOMINAL RADICAL TRACHELECTOMY SPARING THE UTERINE ARTERIES ( A.R.T.- S.U.A) & THE PELVIC AUTONOMIC PLEXUS (P.P.A.P.) IN CERVICAL CANCER (CC): ONCOLOGICAL & FERTILITY OUTCOMES OF THIS NOVEL SURGICAL TECHNIQUE 101A. Soderini, A. Aragona, E. Bonavía, P. Mollar Vigh, M.V. Minaudo, E. Petrocino, L. Di Biase, N. Cuneo (Argentina)

28 UTERINE CERVICAL CANCER RECURRENCE PATTERN IN HIGUERAS HOSPITAL,TALCAHUANO - CHILE,BETWEEN 2003 AND 2014. 102A. Vigueras, M. Hinostroza, J. Araneda, A. Moraga (Chile)

29 CYTOHISTOLOGICAL CORRELATION IN CPU HIGUERAS HOSPITAL, TALCAHUANO - CHILE, BETWEEN 2003 AND 2014. 103E. Vivaldi, A. Vigueras, V. Ruf (Chile)

30 DISEASE RECURRENCE AFTER LOOP TREATMENT FOR HIGH GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA 104J.Y. Yoneda, L.C. zeferino, M. Marangoni, M.P. Funari, T. Sapper, C.A. Hartman, O.F. Rangel, J.F. Braganca (Brazil)

31 EVALUATION OF CONE DEPTH TO ACHIEVE NEGATIVE MARGINS AFTER ELECTROSURGICAL TREATMENT FOR HIGH GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA 105J.Y. Yoneda, L.C. zeferino, M.P. Funari, M. Marangoni, T. Sapper, E.C. Candido, J.F. Braganca (Brazil)

03. Gestational Trophoblastic Neoplasia32 GESTATIONAL TROPHOBLASTIC DISEASE: INCREASE OF INCIDENCE IN

CARLOS VAN BUREN HOSPITAL, VALPARAISO - CHILE 106C. Bazan, S. Parry, H. Riesle (Chile)

33 MOLECULAR CHARACTERIzATION OF GESTATIONAL TROPHOBLASTIC DISEASE 107I. Castillo, J. Lopez, J.E. Leiva, C. Paredes, R. Correa (Chile)

POST

ERS

Poster No.

Presentation No.

POSTERS

25

04. Imaging / Staging34 ROLE OF INDOCYANINE GREEN (ICG) IN SENTINEL NODE MAPPING IN

GYNECOLOGIC CANCER: A TIME FOR A NEW STANDARD OF CARE? 108M.C. Darin, N. Rodriguez Gómez-Hidalgo, P. Escobar, M. Frumovitz, P.T. Ramirez (Argentina)

35 LAPAROSCOPIC TREATMENT FOR ISOLATED PARA-AORTIC LYMPH NODE RECURRENCE 109G. Saraniti, M.T. Labanca, J.M. Saadi, R. Orti, M. Perrotta (Argentina)

05. Nursing, Symptom Management, Palliation36 MOST QUALITY OF LIFE QUESTIONNAIRES USED IN PEER-REVIEWED

CERVICAL CANCER SURVIVALS SURVEYS ARE NOT DISEASE-SPECIFIC INSTRUMENTS AND HAVE NOT BEEN PREVIOUSLY VALIDATED 110L.M. Campbell, W.Q. Primo, R.F. Miziara, P.V. Brito, L.A. Casulari (Brazil)

37 ASSESSMENT OF POSTOPERATIVE MORBIDITY RISK AFTER HYSTERECTOMY USING THE SURGICAL APGAR SCORE 111T. Shemshedini, T.S. Pradhan, S. Labrecque, F. Moy, S.S. Tedjarati, T.L. Pua (USA)

38 THE RELATIONSHIP BETWEEN SELF-EFFICACY AND ADHERENCE TO PAP TEST IN A GROUP OF CHILEAN WOMEN 112M.T. Urrutia (Chile)

06. Ovarian Cancer39 BRAIN METASTASES FROM EPITHELIAL OVARIAN CANCER: CLINICO-

PATHOLOGICAL FINDINGS. A RETROSPECTIVE SINGLE INSTITUTION STUDY 113R. Correa, C. Paredes, J.E. Leiva, R. Munoz, G. Avendano, I. Castillo (Chile)

40 LEPTIN PROMOTES A MORE AGGRESIVE BEHAVIOR OF OVARIAN CANCER CELLS: A POTENTIAL EXPLANATION FOR A WORSE PROGNOSIS IN OBESE OVARIAN CANCER PATIENTS 114M. Cuello-Fredes, S. Kato, L. Abarzúa-Catalán, A. Delpiano, C. Trigo, K. García, C. Sanhueza, C. Ibañez, J. Brañes, E. Castellon, G. Owen (Chile)

POSTERS

Poster No.

Presentation No.

POSTERS

26

41 DIFFERENTIALLY EXPRESSED MIRNAS AND THEIR SURVIVAL PREDICTION IN THE HIGH GRADE SEROUS AND CLEAR CELL OVARIAN CARCINOMA 115S. Cui, G. Wang, X. zhang, X. Wu, J. zhao, X. Yu, Y. Ding (China)

42 ADVANCED STAGE OF EPITHELIAL OVARIAN CANCER (II-IV FIGO STAGE). THE ROLE OF LYMPH NODE DISSECTION 116E. Ismail, Y. Kornovski (Bulgaria)

43 SURGICAL STAGING OF OVARIAN CANCER ( I FIGO STAGE) 117E. Ismail, Y. Kornovski (Bulgaria)

44 ADVANCED OVARIAN CANCER: A CHILEAN UNIVERSITY HOPITAL EXPERIENCE. 118J. Brañes Yunusic, K. Garcia Astudillo, M. Cuello Fredes, D. Majerson Burztyn, N. Barrena Medel, D. Young Hwang, A. Lehuede Massa, N. Saez Orellana, M.V. Perez Mendez (Chile)

45 LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS 119R. Ness, C. Pearce, D. Stram, A. Berchuck, M. Pike, P. Pharoah (USA)

46 DOES TALC EXPOSURE CAUSE OVARIAN CANCER? 120R. Ness (USA)

47 SEROUS PSAMMOCARCINOMA OF THE OVARY AND PERITONEUM: LONG TERM RECURRENCE 121G. Norese, A. Moreira, S. Alessandria, F. Gorosito, M.J. Lange, A. Bermudez (Argentina)

48 IFOSFAMIDUM AS PALLIATIVE TREATMENT FOR ADVANCED OVARIAN CANCER 122S. PLATE, z. zvirbule, S. Kasperova (Latvia)

49 CLINICAL MANAGEMENT OF BORDERLINE OVARIAN TUMORS IN DR SOTERO DEL RIO HOSPITAL 123O. Puga, M.V. Perez, M. Farias, N. Saez, M.I. Barriga, K. Garcia, M. Saavedra, M. Fernandez, T. Rodriguez (Chile)

50 NHE1 PROMOTE CELL PROLIFERATION IN OVARIAN CANCER: A ROLE OF HYPOXIA-INDUCIBLE FACTORS. 124C. Sanhueza, J. Araos, L. Naranjo, T. Sáez, L. Silva, R. Salsoso, F. Pardo, A. Leiva, M.A. Cuello, M. Cornejo, M.A. Ramírez, L. Sobrevia (Chile)

POST

ERS

Poster No.

Presentation No.

POSTERS

27

51 CAN WE IMPROVE DETECTION OF BORDERLINE OVARIAN TUMORS? 125L. Singh, T. Pua, S. Tedjarati, C. Song, L. LeCompte, T. Pradhan (USA)

52 FIBRIN SEALANT HEMOSTATIC PATCH CLINICAL EFFECTIVENESS EVALUATION IN ADVANCED OVARIAN CANCER PATIENTS UNDERWENT PELVIC LYMPHADENECTOMY: INSTITUTIONAL EXPERIENCE 126D.R. Kaidarova, T.A. Yugai, T.T. Sadykova (Kazakhstan)

07. Uterine Cancer, including Sarcoma53 ROBOTIC SURGERY INCREASES PATIENT’S ACCESS TO MINIMALLY

INVASIVE SURGERY FOR HYSTERECTOMIES 127G. Forde, J. Chang, z. A, K. Tewari, R. Bristow (USA)

54 MOLECULAR FINGERPRINTS OF MIXED ENDOMETRIOID AND SEROUS ADENOCARCINOMA OF THE ENDOMETRIUM. 128P. Mhawech-Fauceglia (USA)

55 EARLY STAGE ENDOMETRIAL CANCER: LAPAROSCOPY VS LAPAROTOMY 129S. Alessandria, G. Norese, F. Gorosito, M.J. Lange, M. Nölting, A. Bermudez (Argentina)

56 THE SIGNIFICANCE OF PRE-OPERATIVE ENDOMETRIAL SAMPLING IN GRADE 1, LOW RISK ENDOMETRIAL CANCERS 130L. Singh, T. Pua, P. Khattar, L. Han, S. Tedjarati, T. Pradhan (USA)

57 TWO CASE OF ATYPICAL ENDOMETRIAL HYPERPLASIA ASSOCIATED WITH “BIOIDENTICAL” HORMONE REPLACEMENT THERAPY 131L. Vrabic Dezman, M.z. Gersak, K. Gersak (Slovenia)

58 UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR 132W. Jimenez, J. Maxwell, D. Daya, M. Sur, L. Elit, L. Eiriksson, C. Reade, A. Lytwyn (Canada) PO

STERS

Poster No.

Presentation No.

POSTERS

28

08. Vulvar and Vaginal Cancer59 LASER VAPORIzATION IN VULVAR INTRAEPITHELIAL NEOPLASIA (VIN),

VAGINAL INTRAEPITHELIAL NEOPLASIA (VAIN) AND CONDYLOMATA ACUMINATA 133S. Ramirez, N. Barrena, Y. MC Conell, P. Torres, H. Leon, P. Jimenez, D. Acuna, M. Meneses (Chile)

60 PROGNOSTIC SIGNIFICANCE OF TUMOR SIzE IN SQUAMOUS CELL CARCINOMA OF THE VULVA 134A. Soderini (Argentina)

POST

ERS

IGCS2015

29

INDEX OF AUTHORS

A, z. 127

Abarzúa-Catalán, L. 114

Abu Rustum, N. 16, 28, 66F, 71

Acuña Aravena, D. 80

Acuna, D. 133

Alam, F. 78

Alessandria, S. 121, 129

Almeida, R.V. 97

Alonio, L.V. 100

Amaral, H. 80

Anderson, P. 99

Anorlu, R. 21

Anselmi, M.C.B. 96

Aragona, A. 54, 101

Araneda, J. 102

Araos, J. 124

Arseneau, J. 50

Arturo, N. 75

Audretsch, W. 77, 79

Avendano, G. 113

Bacabasa, N. 76, 81

Bae, S.N. 90

Baiocchi, G. 36

Balescu, I. 81

Barakat, R. 4

Barrena Medel, N. 118

Barrena, N. 66A, 66E, 70, 80, 133

Barriga, M.I. 123

Basiletti, J.A. 100

Basso, O. 50

Bazan, C. 82, 83, 106

Berchuck, A. 119

Bermudez, A. 2, 121, 129

Blancas, S. 98

Boelke, E. 77, 79

Bojar, H. 79

Bonavía, E. 101

Bookman, M. 5, 41, 57, 60

Botha, H. 11, 66G, 72

Bover, S. 46

Braganca Bastos, J. 84

Braganca, J.F. 104, 105

Branes , J. 66D, 69

Brañes Yunusic, J. 91, 118

Brañes, J. 114

Bristow, R. 48, 127

Brito, P. 85

Brito, P.V. 110

Budach, W. 77, 79

Campbell, L. 85

Campbell, L.M. 58, 110

Candido, E.C. 105

Carcamo, M. 86

Castellon, E. 114

Castillo, I. 107, 113

Castro Nessim, E. 46

Casulari, L. 85

Casulari, L.A. 110

Chang, H.K. 90

Chang, J. 48, 127

Cho, Y.L. 87, 88

Chong, G.O. 87, 88

Chopra, M. 78

Coleman, R.L. 52

Cordova, A. 66I, 74

Cornejo, M. 124

Correa, R. 3, 7, 107, 113

Covens, A. 17, 62

Cuello Fredes, M. 91, 118

Cuello-Fredes, M. 114

Cuello, M. 66B, 67

Cuello, M.A. 124

Cui, S. 115

Cuneo, N. 54, 101, 100

Dae Gy, H. 87, 88

Damiani, F. 95

Darin, M.C. 108

David, L. 76

Daya, D. 132

De Dios, D. 95

Delpiano, A. 114

Di Biase, L. 101

Di Guilmi, J. 52

Ding, Y. 115

Dinu, I. 76

Eifel, P.J. 12, 34, 42, 66H, 73

Eiriksson, L. 132

Elit, L. 132

Escobar, P. 108

Etcheverry, G. 100

Farias, M. 123

Fernandez, M. 123

Figueiredo, S.M. 84

Fleming, G. 31, 43

Forde, G. 48, 127

Frumovitz, M. 108

Fujiwara, K. 63

Funari, M.P. 104, 105

30

Garcia Astudillo, K. 91, 118

Garcia, K. 123, 114

Garrido, J. 86

Gayan, P. 86

Gerber, P.A. 77

Gersak, K. 131

Gersak, M.z. 131

Gianni, S. 95

Giavedoni, M. 89

Gilbert, L. 50

Gimenez, L. 95

Gorosito, F. 121, 129

Gotlieb, W. 18

Gottlieb, D. 97

Greco, A. 54

Gurgel, M.S.C. 84

Han, L. 130

Hartman, C.A. 84, 104

Hashemi, E. 99

Hemida, Y. 99

Herbert, G. 32

Hernandez, C. 46

Herzog, T. 14, 35

Hinostroza Scheel, M.

91

Hinostroza, M. 102

Huang, O.P. 92

Ibañez, C. 114

Ismail, E. 116, 117

Jasnis, M.A. 95

Jiang, W. 92

Jimenez, P. 133

Jimenez, W. 132

Kaidarova, D.R. 126

Kasperova, S. 122

Kato, S. 114

Khattar, P. 130

Ki, E.Y. 90

Kim, J.Y. 87

Kim, M.J. 88

Kornovski, Y. 116, 117

Labanca, M.T. 109

Labrecque, S. 111

Lange, M.J. 121, 129

Lay, L. 95

Leckmann, S. 54

LeCompte, L. 125

Ledermann, J. 64

Lee, K.H. 90

Lee, Y.H. 87, 88

Lee, Y.K. 90

Lee, Y.S. 87, 88

Lehuede Massa, A. 91, 118

Leiva, A. 124

Leiva, J.E. 66C, 68, 107, 113

Leon, H. 133

Li, L. 92

liang, M.R. 92

Lio, S. 50

Lopes da Silva Filho, A.

6

Lopez, J. 107

Lu, K.H. 52

Lupo, E. 95

Lytwyn, A. 132

Majerson Burztyn, D.

91, 118

Marangoni, M. 104, 105

Marino, L. 95

Martiniuc, A. 76

Matuschek, C. 77, 79

Maxwell, J. 132

Mayerson, D. 15

MC Conell, Y. 133

Mc Pherson, S. 78

McConell, Y. 80

Medina-Berlanga, R.

98

Mehran, R. 52

Meneses, M. 133

Mhawech-Fauceg-lia, P.

128

Minaudo, M.V. 101

Mir, Y. 78

Miziara, R. 85

Miziara, R.F. 110

Mollar Vigh, P. 101

Moraga, A. 102

Moreira, A. 121

Moy, F. 111

Munoz, R. 113

Naranjo, L. 124

Nazzal, O. 25

Ness, R. 119, 120

Nestle Krämling, C. 77

Nestle, K. 79

Nick, A.M. 52

Noll, F. 93, 94

Nölting, M. 129

Norese, G. 121, 129

Novoa, A. 75

Odetto, D. 93, 94

Okamato, A. 38

Orti, R. 89, 109

Ostojich, M.A. 95

Owen, G. 114

Pardo, F. 124

Paredes Martinez, C.

91

Paredes, C. 107, 113

Park, J.Y. 88

Parry, S. 82, 83, 106

Pearce, C. 119

Perez Mendez, M.V.

118

Perez, M.V. 123

IGCS2015

31

Perrotta, M. 89, 93, 94, 109

Pessini, S. 96

Pessini, S.A. 97

Petrocino, E. 101

Pharoah, P. 119

Picconi, M.A. 100

Pike, M. 119

Pitter, M. 99

Plante, M. 9, 27

PLATE, S. 122

Pradhan, T. 125, 130

Pradhan, T.S. 111

Prado, S. 86

Primo, W. 85

Primo, W.Q. 110

Pruzzo, R. 80

Pua, T. 125, 130

Pua, T.L. 111

Puente, R. 39

Puga, O. 123

Quinn, M. 1, 61

Ramirez, H. 22

Ramírez, M.A. 124

Ramirez, P.T. 52, 108

Ramirez, S. 133, 80

Rangel, O.F. 84, 104

Rao, S. 99

Reade, C. 132

Reyes, C. 54

Richards, L. 78

Riesle, H. 82, 83, 106

Rodriguez Gómez-Hidalgo, N.

108

Rodriguez, T. 123

Ruf, V. 103

Rutgers, J. 37, 40, 59, 66

Saadi, J. 93, 94

Saadi, J.M. 89, 109

Saavedra, M. 123

Sadykova, T.T. 126

Saez Orellana, N. 91, 118

Saez, N. 123

Sáez, T. 124

Salas, C. 65

Salcedo, M.P. 96, 97

Salsoso, R. 124

salvo, G. 94, 52, 89

Sanchez, A. 95

Sanhueza, C. 114, 124

Santos, L. 98

Sapper, T. 104, 105

Saraniti, G. 93, 94, 109

seader, K. 99

Selman, A. 86

Shemshedini, T. 111

Sierra, C. 86

Silva, L. 124

Silveira, G.P.G. 96

Singh, L. 125, 130

Sobrevia, L. 124

Soderini, A. 100, 134, 33, 54, 101

Sommers, G. 99

Song, C. 125

Sood, A.K. 52

Speer, V. 77, 79

Stoica, C. 81

Stram, D. 119

Sur, M. 132

Tatti, S. 23

Tedjarati, S. 125, 130

Tedjarati, S.S. 111

Teixeira, J.C. 84

Tewari, K. 20, 37A, 127

Tisné, J. 26

Todeschini, D.P. 97

Torres, P. 80, 133

Trigo, C. 114

Urrutia, M.T. 112

Valencia, O. 86

Vaporciyan, A. 52

Vargas, N. 46

Velasquez, A. 24

Vico, C. 46

Vidaurreta, J. 46

Vigueras, A. 102, 103

Villalobos, M. 86

Vivaldi, E. 103

Vornetti, S. 100

Vrabic Dezman, L. 131

Wang, G. 115

Wendling, C. 86

Wollandt, S. 77

Wong, H. 78

Wu, X. 115

Yoneda, J.Y. 84, 104, 105

Young Hwang, D. 91, 118

Yu, X. 115

Yugai, T.A. 126

zeferino, L.C. 104, 105

zeff, N. 95

zeng, S.Y. 92

zevallos, A. 10

zhang, X. 115

zhao, J. 115

zhong, M.L. 92

ziogas, A. 48

zvirbule, z. 122

32

RECOGNITION, ACKNOWLEDGEMENTS AND INDUSTRY SUPPORTACKNOWLEDGEMENTSThe Organizing Committee of the 4th Regional IGCS Meeting, 2015 would like to express its gratitude and acknowledge the following for their generous support of the Meeting:

SILVER SPONSOR

EXHIBITORS

COMPANY ORGANIZED SYMPOSIUM Roche Chile LTDA

Friday May 10, 2015 from 12:30 till 13:30

UPDATE IN THE MANAGEMENT OF ADVANCED CERVICAL CANCER, THE ROLE OF BEVACIZUMAB

12:30 -12:35 Welcome - Ximena Ahumada, Chile

12:35 -12:50 Introducción: Cáncer Cérvix en Chile - Nicanor Barrena, Chile

12:50 -13:20 Update in the management of advanced cervical cancer, the role of Bevacizumab - Krishnansu S. Tewari, USA

13:20-13:30 Discussion

IGCS2015

33

SPONSOR AND EXHIBITOR PROFILES

BIOSONDA S.A.Alcalde Eduardo Castillo Velasco 2902 775 0269SantiagoChile www.biosonda.clThe HC2 HPV DNA Test –the gold standard for HPV detection- certified by FDA and CE is produced by digene for Qiagen. It uses a RNA probe cocktail that detects 13 high-risk HPV and 5 low-risk types. To prevent false negatives caused by gene deletions uses a full genome RNA probes complementary to HPV DNA, specific antibodies, signal amplification, and chemiluminescent detection. The HC2 Test can be used with the digene HC2 DNA Collection Device and ThinPrep Pap Test PreservCyt solution to complement PAP. It is currently used for screening of HPV in: Argentina, Mexico, Turkey, Italy and USA among others. HC2 is distributed in Chile by Biosonda S.A.

ECHODATA MEDICAL SYSTEMS CHILE SPAHernando de Aguirre 128, Office 505. ProvidenciaSantiago 7500000Chilewww.echodatallc.comEchodata Medical Systems ha permanecido en crecimiento constante; posicionándose como uno de los proveedores más importantes de Equipos Médicos para Latinoamérica establecidos en la ciudad de Miami y ahora en Chile. Hemos incursionado en el Mercado Chileno a traves de ECHODATA CHILE SpA en la venta y distribución Exclusiva de los Sistemas AMEU (Aspiracion Manual Endo Uterina) destinados al area Gynecologica y de algunos Sistemas dirigidos al tratamiento de lesiones Pre Cancerosas de Cuello Uterino y Cancer Cervical. Nuestra posición como Dealer en los Sistemas AMEU (Aspiracion Manual Endo Uterina), nos ha permitido tener contacto con clientes en toda la región, y nos ha dado el impulso para desarrollar nuevas ideas y conceptos propios, atendiendo y sobrepasando las necesidades de los exigentes mercados. Nuestro objetivo es seguir consolidando estas áreas y continuar innovando, atendiendo los requerimientos del pujante mercado de la salud de Latinoamérica, en especial el mercado Chileno.

F. HOFFMANN-LA ROCHE AG Avenida Cerro el Plomo 5630, P 12, Las CondesRegión MetropolitanaChilewww.roche.cl F. Hoffmann-La Roche AG is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticalsand Diagnostics. Its holding company, Roche Holding AGThe company headquarters are located in Basel and the company has many pharmaceutical and diagnostic sites around the world . There are 26 manufacturing sites worldwide.The company owns the American biotechnology company Genentech, which is a wholly owned affiliate, and the Japanese biotechnology company Chugai Pharmaceuticals as well as the Tucson, Arizona based Ventana}In Roche Farma our business focuses on the therapeutic areas of oncology-hematology, rheumatology, transplantation, anemia, hepatitis and Central Nervous System

34

THE CHILEAN SOCIETY OF GYNECOLOGIC ONCOLOGY (SCHIGO)The Chilean Society of Gynecologic Oncology was founded on October 31th, 2001 in Santiago of Chile, with 42 selected founding members. All of them were convened - considering their acknowledged trajectory in the field of gynecologic cancer - by 3 Chairman of Obstetrics and Gynecology Departments of prestigious Chilean universities (Austral University, Catholic University and University of Chile). The first and founder President was Raul Puente MD from Austral University. The aim of the Society was the study of gynecologic cancer as much in prevention as in pathological aspects, but in special in the field of gynecologic oncology surgery. On October 7th, 2004, the Society got its legal status. During 2005, the Society obtained the recognition of Gynecologic Oncology as subspeciality in Chile by CONACEM, an indepent Agency of Certification. Since then, there are numerous gynecologic oncologist board-certified in the country. Since 2004, the Chilean Society of Gynecologic Oncology has organized succesfully 3 National Congress and 2 National Meetings of Gynecologic Oncology with outstanding invited international lecturers, and some of its members have been invited to present in IGCS Meetings.Prof. Raul Puente MD President SCHIGO

THE CHILEAN SOCIETY OF OBSTETRICS AND GYNECOLOGY (SOCHOG)The Chilean Society of Obstetrics and Gynecology was founded on October 15, 1935, in a meeting attended by 19 participants, giving birth to the third of the oldest national scientific associations and the longest fourth of its kind in Latin America .The Society was created with the aim of combining the criteria of the different departments of the specialty and mainstream doctors who excelled in their development, in order to spread the level of the medical establishment and to provide information to the public to improve the quality of care for women. With 80 years of history there are many milestones that have marked the path of SOCHOG, including the creation of the “Chilean Bulletin of Obstetrics and Gynecology” and in the 60s the “Chilean Journal of Obstetrics and Gynecology”, with better design more numbers of pages and bimonthly.In 2007, the Sochog helped the creation of the Chilean Chapter of the American College of Obstetrician and Gynecologists (ACOG), created in 1951.With the Chilean female population going above the 8 million mark, who are averaging the age of 82 years, the objective of the Sochog has been changing and growing. It is from here that the current president, the Doctor Mauricio Cuello Fredes, has found the problem that the SOCHOG has to encounter in its eighth decade. “We want the Gynecologist Obstetrician to go further that a doctor who only worries about the pregnancy, delivery and the puerperal or just the problems associated with gynecology and reproduction. The idea is for them to become a lifelong doctor, a confidant for the woman through her life.

IGCS • PO Box 6387, Louisville • KY 40206, USA • Voice: 1-(502)-891-4575 • FAX: 1-(502)[email protected] • www.igcs.org

Join...The International Communityof Gynecologic Cancer ProfessionalsMember Benefits Include:

Subscription to the peer-reviewed International Journal of Gynecological Cancer, published nine times a yearIGCS Newsletter, published twice a yearIGCS Membership Directory and Speaker’s BureauTravel Scholarships and GrantsVirtual Tumor Board, Journal Club, Lecture Slides, Webcasts, Guidelines, and other educational resourcesReciprocal relationship with other societies

IGCS • PO Box 6387, Louisville • KY 40206, USA • Voice: 1-(502)-891-4575 • FAX: 1-(502)[email protected] • www.igcs.org

Join...The International Communityof Gynecologic Cancer ProfessionalsMember Benefits Include:

Subscription to the peer-reviewed International Journal of Gynecological Cancer, published nine times a yearIGCS Newsletter, published twice a yearIGCS Membership Directory and Speaker’s BureauTravel Scholarships and GrantsVirtual Tumor Board, Journal Club, Lecture Slides, Webcasts, Guidelines, and other educational resourcesReciprocal relationship with other societies

SUNDAY, MAY 10, 2015Time Session

08:45-09:00 Welcome to Santiago and the IGCS Regional Meeting

09:00-09:15 PRESIDENTIAL ADDRESS: What Latin American Oncologists Should Expect from IGCS?

09:15-09:30 How Latin America Could Contribute to Gynecologic Oncology Research

09:30-09:45 Current Status of Collaborative Clinical Research in South America

09:45-10:00 The Role of Palliative Care / Supportive Oncology Team

10:00-10:15 Panel Discussion, Regional Clinical Research

10:15-10:30 Coffee Break, Poster Viewing & Visit the Exhibition

10:30-10:45 Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Staging Approach

10:45-11:00 Role of Laparoscopy in Gynecologic Oncology

11:00-11:15 Advantages of Robotic Surgery over Laparoscopic Approach in Gynecological Malignancies

11:15-11:30 Panel Discussion, Regional Surgical Practices

11:30-11:50 Surgical Considerations in the Management of Vulvar Cancer

11:50-12:10 Adjuvant Treatment for Vulvar Cancer

12:10-12:30 Panel Discussion, Vulvar Cancer Management (+/- case presentation)

12:30-13:30 Lunch Break, Poster Viewing & Visit the Exhibition

12:30-13:30Update in the Management of Advanced Cervical Cancer. The Role of Bevacizumab - Symposium Sponsored by Roche Chile LTDA

13:30-14:00 Strategies for Cervical Cancer Prevention in Latin America: Past, Present and Future

14:00-14:30 Panel Discussion: Cervical Cancer Prevention

14:30-14:50 Fertility Sparing Options in Cervical Cancer

14:50-15:10 Radical Abdominal Trachelectomy with SLN for Stage IB1 Cervical Cancer

15:10-15:30 Panel Discussion, Fertility Sparing Surgery


16:00-16:20 Is there a Role for Neoadjuvant Chemotherapy of Cervical Cancer?

16:20-16:40Optimal Integration of Radiation Therapy in the Management of Locally Advanced Cervical Cancer

16:40-17:00 Uterine Sarcomas

17:00-17:30 Tumor Board: Cervical Cancer

17:45 Opening Ceremony

MONDAY, MAY 11, 2015 Time Session

08:30-08:50 Current Staging and Pathological Considerations in Endometrial Cancer

08:50-09:10 Clinical Significance of Non-Endometrioid Tumors

09:10-09:30 Radiotherapy in Endometrial Cancer

09:30-09:50 Chemotherapy in Endometrial Cancer

09:50-10:30 Panel Discussion, Endometrial Cancer (+/- cases)


11:30-12:45 Oral Abstracts

12:45-14:00 Lunch Break, Poster Viewing & Visit the Exhibition

14:00-14:20 Pathological Features of Epithelial Ovarian and Associated Cancers

14:20-14:40 Low Malignant Potential Ovarian Tumors

14:40-15:00 Is There a Role for Adjuvant Treatment of Early Stage Disease (Serous and Non-serous)?

15:00-15:20 The Role of Neoadjuvant Therapy and Definitions of Residual Disease in 2015

15:20-15:50 Optimal Primary Chemotherapy, including Dose-Dense and Intraperitoneal Therapy

15:50-16:20 Targeting Recurrent Ovarian Cancer

16:20-17:30 Tumor Board: Ovarian Cancer

TUESDAY, MAY 12, 2015 Time Session08:30-14:00 Surgical Day

09:00-11:00 Radiation Oncology Symposium, Contouring and Target Volume Definition

14:00-14:30 Final Remarks and Close

TIMETABLE

REGIONAL IGCS MEETING 2015SANTIAGO, CHILE MAY 10-12, 2015

TH

international gynecologic cancer symposium...

Documents